User profiles for MICHALIS KARAMOUZIS
 | MICHALIS KARAMOUZISNational and Kapodistrian University of Athens Verified email at med.uoa.gr Cited by 25492 |
[HTML][HTML] Machine learning applications in cancer prognosis and prediction
Cancer has been characterized as a heterogeneous disease consisting of many different
subtypes. The early diagnosis and prognosis of a cancer type have become a necessity in …
subtypes. The early diagnosis and prognosis of a cancer type have become a necessity in …
Head and neck cancer
Most head and neck cancers are squamous cell carcinomas that develop in the upper
aerodigestive epithelium after exposure to carcinogens such as tobacco and alcohol. Human …
aerodigestive epithelium after exposure to carcinogens such as tobacco and alcohol. Human …
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
PA Konstantinopoulos, MV Karamouzis… - Nature reviews Drug …, 2007 - nature.com
The involvement of the RAS superfamily of monomeric GTPases in carcinogenesis is
increasingly being appreciated. A complex array of post-translational modifications and a highly …
increasingly being appreciated. A complex array of post-translational modifications and a highly …
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma …
…, P Yanez, M Tehfe, R Kowalyszyn, MV Karamouzis… - The Lancet, 2021 - thelancet.com
Background First-line chemotherapy for advanced or metastatic human epidermal growth
factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma …
factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma …
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
…, J Taieb, MV Karamouzis… - … England Journal of …, 2023 - Mass Medical Soc
Background KRAS G12C is a mutation that occurs in approximately 3 to 4% of patients with
metastatic colorectal cancer. Monotherapy with KRAS G12C inhibitors has yielded only …
metastatic colorectal cancer. Monotherapy with KRAS G12C inhibitors has yielded only …
[HTML][HTML] Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
…, JM Cleary, P Yanez, K Feeney, MV Karamouzis… - Nature, 2022 - nature.com
Standard first-line chemotherapy results in disease progression and death within one year
in most patients with human epidermal growth factor receptor 2 (HER2)-negative gastro-…
in most patients with human epidermal growth factor receptor 2 (HER2)-negative gastro-…
Immunotherapy for pancreatic cancer: A 2020 update
Pancreatic adenocarcinoma (PAC) is associated with extremely poor prognosis and
remains a lethal malignancy. The main cure for PAC is surgical resection. Further treatment …
remains a lethal malignancy. The main cure for PAC is surgical resection. Further treatment …
[PDF][PDF] Hormonal responses after various resistance exercise protocols
I Smilios, T Pilianidis, M Karamouzis… - Medicine & Science in …, 2003 - paulogentil.com
… ILIAS SMILIOS1, THEOPHILOS PILIANIDIS1, MICHALIS KARAMOUZIS2, and SAVVAS P. …
KARAMOUZIS, and SP TOKMAKIDIS. Hormonal Responses after Various Resistance …
KARAMOUZIS, and SP TOKMAKIDIS. Hormonal Responses after Various Resistance …
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide,
but credible estimates from the World Health Organization and the International Agency for …
but credible estimates from the World Health Organization and the International Agency for …
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
EG Iliopoulou, P Kountourakis, MV Karamouzis… - Cancer immunology …, 2010 - Springer
HLA-mismatched natural killer (NK) cells have shown efficacy in acute myeloid leukemia,
and their adoptive transfer in patients with other malignancies has been proven safe. This …
and their adoptive transfer in patients with other malignancies has been proven safe. This …